BioSpace News Archive

The Sapienza University of Rome is now using the digital teaching platform from the international medical imaging and cybersecurity company Sectra (STO: SECT B) to continue its doctor training remotely.

Hoth Therapeutics, Inc. (NASDAQ: HOTH) (the “Company’ or “Hoth”), a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from dermatological indications ranging from atopic dermatitis, psoriasis and acne as well as gene therapy treatment for asthmatics, today announced results from a preclinical study demonstrating the potential effectiveness of WEG232,

Company converts CDC guidance into interactive decision-tool in its free epocrates® mobile app, facilitates connectivity to telehealth partners, and ensures availability of commercial lab tests within ordering workflow

COVID-19 has drastically changed the world’s social and economic landscape since the virus was first identified in China in January.

CTCA Welcoming Community Hospital Cancer Patients; President and CEO Dr. Pat Basu Available to Discuss Role Specialty Hospitals Can Play During Pandemic

Northwell Health announced that it would delay payments with zero percent interest for a minimum of 60 days for those patients who receive medical services and have been financially impacted with the loss of a job, lost wages or other financial distress resulting from the COVID-19 pandemic.

Trinity Life Sciences, a leader in global life sciences solutions, announces the availability of Trinity EthnoCapture, a digital approach to understanding the patient journey.

Global health and hygiene company RB, maker of Lysol, Air Wick, Mucinex, Enfamil and more, announced a collaboration with life sciences knowledge discovery platform company Eagle Genomics.

Robert Kaplan, PhD, a renowned authority in healthcare and health services research was awarded the 2020 Elizabeth Fries Health Education Award.

Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), an ocular health sciences company that, among other things, develops, formulates, manufacture and distributes condition-specific medical foods supported by evidence-based protocols, and provides ocular testing, announced today that it received a letter from the Listing Qualifications Department of The NASDAQ Capital Market (“Nasdaq”